SOLV · 8-K · 20260805PR000045

Operating Expense Trends

Solventum Corp · 2026-08-05 · Importance 55 · Surprise 66 · No source text

Second-quarter SG&A increased 20.1% year over year to $927 million from $772 million. The increase primarily reflected higher separation-related costs and net legal costs, while adjusted SG&A as a percentage of sales declined 130 basis points to 26.0%. Research and development expense decreased 5.8% to $178 million from $189 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
operating_incomenegativerealized-7.0%Selling, general and administrative (SG&A) expenses for Q2 2026: $927 million, a 20.1% increase year-over-year
operating_incomenegativerealized-6.6%Non-GAAP adjustments in Q2 2026 include $90 million amortization, $42 million restructuring costs, $145 million 3M…
operating_incomenegativerealized-4.1%Non-GAAP adjustments in Q2 2026 include $90 million amortization, $42 million restructuring costs, $145 million 3M…
operating_incomenegativerealized-1.9%Non-GAAP adjustments in Q2 2026 include $90 million amortization, $42 million restructuring costs, $145 million 3M…
operating_incomenegativerealized-0.7%Non-GAAP adjustments in Q2 2026 include $90 million amortization, $42 million restructuring costs, $145 million 3M…
operating_incomenegativerealized-0.3%Non-GAAP adjustments in Q2 2026 include $90 million amortization, $42 million restructuring costs, $145 million 3M…